ScholarLens Back to search
2015•Obstetrical & Gynecological SurveyRequires access

Expanding the Scope of Noninvasive Prenatal Testing

Ronald J. Wapner, Joshua Babiarz, Brynn Levy, Melissa Stosic, Bernhard Zimmermann, Styrmir Sigurjonsson, Nicholas Wayham, Allison Ryan, Milena Banjevic, Phil Lacroute, Jing Hu, Megan P. Hall, Zachary Demko, Asim Siddiqui, Matthew Rabinowitz, Susan J. Gross, Matthew D. Hill, Peter Benn

Open publisher page 2 citations

Abstract

Obstet Gynecol Surv 2015;70(8):481–482 There are noninvasive prenatal testing (NIPT) approaches using cell-free DNA in the maternal circulation to detect those women at high risk of trisomy 21, trisomy 18, trisomy 13, and sex chromosomal abnormalities. This study estimates the success of a single-nucleotide polymorphism (SNP) approach to analyzing maternal cell-free DNA in detecting 5 fetal microdeletion syndromes.

About this research paper

What this paper is about

Obstet Gynecol Surv 2015;70(8):481–482 There are noninvasive prenatal testing (NIPT) approaches using cell-free DNA in the maternal circulation to detect those women at high risk of trisomy 21, trisomy 18, trisomy 13, and sex chromosomal abnormalities. This study estimates the success of a single-nucleotide polymorphism (SNP) approach to analyzing maternal cell-free DNA in detecting 5 fetal microdeletion syndromes.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Obstet Gynecol Surv 2015;70(8):481–482 There are noninvasive prenatal testing (NIPT) approaches using cell-free DNA in the maternal circulation to detect those women at high risk of trisomy 21, trisomy 18, trisomy 13, and sex chromosomal abnormalities. This study estimates the success of a single-nucleotide polymorphism (SNP) approach to analyzing maternal cell-free DNA in detecting 5 fetal microdeletion syndromes.

Key concepts: Trisomy, Cell-free fetal DNA, Medicine, SNP, Prenatal diagnosis, Genetic testing, Single-nucleotide polymorphism, Obstetrics

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Expanding the Scope of Noninvasive Prenatal Testing — Research Paper | ScholarLens